These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20831421)

  • 1. Who's doing the math? Are we really compensating research participants?
    Ripley E; Macrina F; Markowitz M; Gennings C
    J Empir Res Hum Res Ethics; 2010 Sep; 5(3):57-65. PubMed ID: 20831421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do we pay? A national survey of investigators and IRB chairpersons.
    Ripley E; Macrina F; Markowitz M; Gennings C
    J Empir Res Hum Res Ethics; 2010 Sep; 5(3):43-56. PubMed ID: 20831420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misconceptions about coercion and undue influence: reflections on the views of IRB members.
    Largent E; Grady C; Miller FG; Wertheimer A
    Bioethics; 2013 Nov; 27(9):500-7. PubMed ID: 22493972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coercion in the recruitment and retention of human research subjects, pharmaceutical industry payments to physician-investigators, and the moral courage of the IRB.
    DeRenzo EG
    IRB; 2000; 22(2):1-5. PubMed ID: 11883465
    [No Abstract]   [Full Text] [Related]  

  • 5. Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward.
    Largent EA; Fernandez Lynch H
    Yale J Health Policy Law Ethics; 2017; 17(1):61-141. PubMed ID: 29249912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential payment to research participants in the same study: an ethical analysis.
    Persad G; Fernandez Lynch H; Largent E
    J Med Ethics; 2019 May; 45(5):318-322. PubMed ID: 30846490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Payment of research participants: current practice and policies of Irish research ethics committees.
    Roche E; King R; Mohan HM; Gavin B; McNicholas F
    J Med Ethics; 2013 Sep; 39(9):591-3. PubMed ID: 23204324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials.
    Gelinas L; Lynch HF; Largent EA; Shachar C; Cohen IG; Bierer BE
    Ther Innov Regul Sci; 2018 May; 52(3):268-274. PubMed ID: 29714586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payments to research subjects.
    Wilkinson M
    Monash Bioeth Rev; 2005 Jan; 24(1):70-4. PubMed ID: 16007758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons.
    Kodish E; Stocking C; Ratain MJ; Kohrman A; Siegler M
    J Clin Oncol; 1992 Nov; 10(11):1810-6. PubMed ID: 1403062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
    Roizen R
    IRB; 1988; 10(1):9-10. PubMed ID: 11658990
    [No Abstract]   [Full Text] [Related]  

  • 12. Payment to participants in pediatric research: variation in IRB members' attitudes.
    Crites JS; Harter TD; Furman LM; Daly BJ
    IRB; 2013; 35(5):9-13. PubMed ID: 24350503
    [No Abstract]   [Full Text] [Related]  

  • 13. Payment of clinical research subjects.
    Grady C
    J Clin Invest; 2005 Jul; 115(7):1681-7. PubMed ID: 16007244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paradoxical case of payment as benefit to research subjects.
    Macklin R
    IRB; 1989; 11(6):1-3. PubMed ID: 11650284
    [No Abstract]   [Full Text] [Related]  

  • 15. Dilemmas in paying for clinical research: the view from the IRB.
    Lind SE
    IRB; 1987; 9(2):1-5. PubMed ID: 11649900
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of risk and monetary payment on the research participation decision making process.
    Bentley JP; Thacker PG
    J Med Ethics; 2004 Jun; 30(3):293-8. PubMed ID: 15173366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy children as subjects in pharmaceutical research.
    Koren G
    Theor Med Bioeth; 2003; 24(2):149-59. PubMed ID: 12943269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undue inducement: the only objection to payment?
    VanderWalde A
    Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
    [No Abstract]   [Full Text] [Related]  

  • 19. Undue inducement: nonsense on stilts?
    Emanuel EJ
    Am J Bioeth; 2005; 5(5):9-13; discussion W8-11, W17. PubMed ID: 16179296
    [No Abstract]   [Full Text] [Related]  

  • 20. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: a proposal.
    Ndebele P; Mfutso-Bengo J; Mduluza T
    Malawi Med J; 2008 Jun; 20(2):42-5. PubMed ID: 19537431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.